IBDEI1NN ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26426,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,26427,0)
 ;;=I13.11^^107^1242^11
 ;;^UTILITY(U,$J,358.3,26427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26427,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,26427,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,26427,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,26428,0)
 ;;=I13.2^^107^1242^9
 ;;^UTILITY(U,$J,358.3,26428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26428,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,26428,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,26428,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,26429,0)
 ;;=I15.0^^107^1242^15
 ;;^UTILITY(U,$J,358.3,26429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26429,1,3,0)
 ;;=3^Renovascular Hypertension
 ;;^UTILITY(U,$J,358.3,26429,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,26429,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,26430,0)
 ;;=I15.1^^107^1242^3
 ;;^UTILITY(U,$J,358.3,26430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26430,1,3,0)
 ;;=3^Hypertension Secondary to Oth Renal Disorders
 ;;^UTILITY(U,$J,358.3,26430,1,4,0)
 ;;=4^I15.1
 ;;^UTILITY(U,$J,358.3,26430,2)
 ;;=^5007072
 ;;^UTILITY(U,$J,358.3,26431,0)
 ;;=I15.2^^107^1242^2
 ;;^UTILITY(U,$J,358.3,26431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26431,1,3,0)
 ;;=3^Hypertension Secondary to Endocrine Disorders
 ;;^UTILITY(U,$J,358.3,26431,1,4,0)
 ;;=4^I15.2
 ;;^UTILITY(U,$J,358.3,26431,2)
 ;;=^5007073
 ;;^UTILITY(U,$J,358.3,26432,0)
 ;;=I15.8^^107^1242^16
 ;;^UTILITY(U,$J,358.3,26432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26432,1,3,0)
 ;;=3^Secondary Hypertension,Oth
 ;;^UTILITY(U,$J,358.3,26432,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,26432,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,26433,0)
 ;;=I15.9^^107^1242^17
 ;;^UTILITY(U,$J,358.3,26433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26433,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,26433,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,26433,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,26434,0)
 ;;=I16.0^^107^1242^14
 ;;^UTILITY(U,$J,358.3,26434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26434,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,26434,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,26434,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,26435,0)
 ;;=I16.1^^107^1242^7
 ;;^UTILITY(U,$J,358.3,26435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26435,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,26435,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,26435,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,26436,0)
 ;;=I16.9^^107^1242^6
 ;;^UTILITY(U,$J,358.3,26436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26436,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,26436,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,26436,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,26437,0)
 ;;=A07.0^^107^1243^5
 ;;^UTILITY(U,$J,358.3,26437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26437,1,3,0)
 ;;=3^Balantidiasis
 ;;^UTILITY(U,$J,358.3,26437,1,4,0)
 ;;=4^A07.0
 ;;^UTILITY(U,$J,358.3,26437,2)
 ;;=^12533
 ;;^UTILITY(U,$J,358.3,26438,0)
 ;;=A07.1^^107^1243^9
 ;;^UTILITY(U,$J,358.3,26438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26438,1,3,0)
 ;;=3^Giardiasis [lambliasis]
 ;;^UTILITY(U,$J,358.3,26438,1,4,0)
 ;;=4^A07.1
 ;;^UTILITY(U,$J,358.3,26438,2)
 ;;=^5000049
 ;;^UTILITY(U,$J,358.3,26439,0)
 ;;=A07.2^^107^1243^7
